{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:22:46Z","timestamp":1788337366337,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Microbiol"],"DOI":"10.1007\/s10123-026-00890-5","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:08:03Z","timestamp":1788332883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibacterial and antibiofilm properties of 1,3,4-oxadiazoles against multidrug-resistant Pseudomonas aeruginosa isolated from burn infections \u2013 an in vitro study"],"prefix":"10.1007","author":[{"given":"Mohsen","family":"Nazari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Majzoobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Yousef","family":"Alikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas Ali","family":"Imani Fooladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"890_CR28","doi-asserted-by":"publisher","first-page":"100646","DOI":"10.1016\/j.mgene.2020.100646","volume":"23","author":"WM Abdelraheem","year":"2020","unstructured":"Abdelraheem WM, Abdelkader AE, Mohamed ES, Mohammed MS (2020) Detection of biofilm formation and assessment of biofilm genes expression in different Pseudomonas aeruginosa clinical isolates. Meta Gene 23:100646","journal-title":"Meta Gene"},{"issue":"3","key":"890_CR47","doi-asserted-by":"publisher","first-page":"e0289586","DOI":"10.1371\/journal.pone.0289586","volume":"19","author":"FA Abdi","year":"2024","unstructured":"Abdi FA, Motumma AN, Kalayu AA, Abegaz WE (2024) Prevalence and antimicrobial-resistant patterns of Pseudomonas aeruginosa among burn patients attending Yekatit 12 Hospital Medical College in Addis Ababa, Ethiopia. PLoS ONE 19(3):e0289586","journal-title":"PLoS ONE"},{"issue":"1","key":"890_CR52","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1038\/s41598-025-98061-5","volume":"15","author":"KF Al-Azawi","year":"2025","unstructured":"Al-Azawi KF, Hasoon BA, Ismail RA, Rasool KH, Jabir MS, Shaker SS et al (2025) Pharmaceutical properties of novel 3-((diisopropylamino) methyl)-5-(4-((4-(dimethylamino) benzylidene) imino) phenyl)-1, 3, 4-oxadiazole-2 (3 H)-thione. Sci Rep 15(1):15019","journal-title":"Sci Rep"},{"key":"890_CR14","doi-asserted-by":"publisher","unstructured":"Ardebili A, Izanloo A, Rastegar M (2023) Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy? Expert Rev Anti Infect Ther 21(4):387\u2013429. https:\/\/doi.org\/10.1080\/14787210.2023.2184346","DOI":"10.1080\/14787210.2023.2184346"},{"issue":"1","key":"890_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/life15010049","volume":"15","author":"K Azeem","year":"2025","unstructured":"Azeem K, Fatima S, Ali A, Ubaid A, Husain FM, Abid M (2025) Biochemistry of bacterial biofilm: insights into antibiotic resistance mechanisms and therapeutic intervention. Life 15(1):49","journal-title":"Life"},{"issue":"3","key":"890_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10096-018-3189-7","volume":"37","author":"AM Bardbari","year":"2018","unstructured":"Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY et al (2018) Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 37(3):443\u2013454","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"890_CR55","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/antibiotics10101258","volume":"10","author":"E Buommino","year":"2021","unstructured":"Buommino E, De Marino S, Sciarretta M, Piccolo M, Festa C, D\u2019Auria MV (2021) Synergism of a novel 1, 2, 4-oxadiazole-containing derivative with oxacillin against methicillin-resistant Staphylococcus aureus. Antibiotics 10(10):1258","journal-title":"Antibiotics"},{"issue":"6","key":"890_CR56","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/jac\/dky064","volume":"73","author":"GP Carter","year":"2018","unstructured":"Carter GP, Harjani JR, Li L, Pitcher NP, Nong Y, Riley TV et al (2018) 1, 2, 4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium. J Antimicrob Chemother 73(6):1562\u20131569","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"890_CR13","doi-asserted-by":"publisher","first-page":"8709","DOI":"10.3390\/ijms24108709","volume":"24","author":"J Chung","year":"2023","unstructured":"Chung J, Eisha S, Park S, Morris AJ, Martin I (2023) How three self-secreted biofilm exopolysaccharides of Pseudomonas aeruginosa, Psl, Pel, and alginate, can each be exploited for antibiotic adjuvant effects in cystic fibrosis lung infection. Int J Mol Sci 24(10):8709","journal-title":"Int J Mol Sci"},{"key":"890_CR54","doi-asserted-by":"crossref","unstructured":"Dante Formagio M, de Oliveira Silva J, Fortunato Prohmann L, Zanetti Campanerut-S\u00e1 P, Grenier Capoci I et al (2022) Seki Kioshima Cotica \u00c9,. New 1, 3, 4\u2010oxadiazole compound with effective antibacterial and antibiofilm activity against Staphylococcus aureus. Lett Appl Microbiol 75(4):957\u2013966","DOI":"10.1111\/lam.13766"},{"issue":"6","key":"890_CR57","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1128\/jcm.35.6.1295-1299.1997","volume":"35","author":"D De Vos","year":"1997","unstructured":"De Vos D, Lim A Jr, Pirnay J-P, Struelens M, Vandenvelde C, Duinslaeger L et al (1997) Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL. J Clin Microbiol 35(6):1295\u20131299","journal-title":"J Clin Microbiol"},{"issue":"1","key":"890_CR59","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2180-9-244","volume":"9","author":"P Deschaght","year":"2009","unstructured":"Deschaght P, De Baere T, Van Simaey L, Van Daele S, De Baets F, De Vos D et al (2009) Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol 9(1):244","journal-title":"BMC Microbiol"},{"issue":"11","key":"890_CR49","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1021\/acsinfecdis.3c00250","volume":"9","author":"EJ Douglas","year":"2023","unstructured":"Douglas EJ, Marshall B, Alghamadi A, Joseph EA, Duggan S, Vittorio S et al (2023) Improved antibacterial activity of 1, 3, 4-oxadiazole-based compounds that restrict Staphylococcus aureus growth independent of LtaS function. ACS Infect Dis 9(11):2141\u20132159","journal-title":"ACS Infect Dis"},{"issue":"87","key":"890_CR58","first-page":"1","volume":"38","author":"TH El-Khashaab","year":"2016","unstructured":"El-Khashaab TH, Erfan DM, Kamal A, El-Moussely LM, Ismail DK (2016) Pseudomonas aeruginosa biofilm formation and quorum sensing lasR gene in patients with wound infection. Egypt J Med Microbiol 38(87):1\u20138","journal-title":"Egypt J Med Microbiol"},{"issue":"9","key":"890_CR26","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3390\/molecules27092709","volume":"27","author":"RM El-Masry","year":"2022","unstructured":"El-Masry RM, Kadry HH, Taher AT, Abou-Seri SM (2022) Comparative study of the synthetic approaches and biological activities of the bioisosteres of 1, 3, 4-oxadiazoles and 1, 3, 4-thiadiazoles over the past decade. Molecules 27(9):2709","journal-title":"Molecules"},{"issue":"1","key":"890_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.34172\/ajcmi.2021.06","volume":"8","author":"S Ghameshlouei","year":"2021","unstructured":"Ghameshlouei S, Ahrabi NZ, Souldozi A, SarveAhrabi Y (2021) Evaluation of the antibacterial and investigation of the molecular docking of new derivatives of 1, 3, 4-oxadiazole as inhibitors of quorum sensing system in the human pathogen Pseudomonas aeruginosa. Avicenna J Clin Microbiol Infect 8(1):27\u201333","journal-title":"Avicenna J Clin Microbiol Infect"},{"issue":"13","key":"890_CR23","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.3390\/ijms22136979","volume":"22","author":"T Glomb","year":"2021","unstructured":"Glomb T, \u015awi\u0105tek P (2021) Antimicrobial activity of 1, 3, 4-oxadiazole derivatives. Int J Mol Sci 22(13):6979","journal-title":"Int J Mol Sci"},{"key":"890_CR50","doi-asserted-by":"publisher","first-page":"104966","DOI":"10.1016\/j.ejps.2019.104966","volume":"136","author":"Y Guo","year":"2019","unstructured":"Guo Y, Xu T, Bao C, Liu Z, Fan J, Yang R et al (2019) Design and synthesis of new norfloxacin-1, 3, 4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA). Eur J Pharm Sci 136:104966","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"890_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s13353-023-00811-6","volume":"65","author":"J Hemmati","year":"2024","unstructured":"Hemmati J, Nazari M, Ahmadi A, Bayati M, Jalili M, Taheri M et al (2024) In vitro evaluation of biofilm phenotypic and genotypic characteristics among clinical isolates of Pseudomonas aeruginosa in Hamadan, West of Iran. J Appl Genet 65(1):213\u2013222","journal-title":"J Appl Genet"},{"issue":"1","key":"890_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12866-024-03249-w","volume":"24","author":"J Hemmati","year":"2024","unstructured":"Hemmati J, Nazari M, Abolhasani FS, Ahmadi A, Asghari B (2024) In vitro investigation of relationship between quorum-sensing system genes, biofilm forming ability, and drug resistance in clinical isolates of Pseudomonas aeruginosa. BMC Microbiol 24(1):99","journal-title":"BMC Microbiol"},{"issue":"7","key":"890_CR19","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1089\/mdr.2017.0101","volume":"24","author":"SY Holbrook","year":"2018","unstructured":"Holbrook SY, Garneau-Tsodikova S (2018) Evaluation of aminoglycoside and carbapenem resistance in a collection of drug-resistant Pseudomonas aeruginosa clinical isolates. Microb drug Resist 24(7):1020\u20131030","journal-title":"Microb drug Resist"},{"key":"890_CR41","doi-asserted-by":"publisher","first-page":"1269392","DOI":"10.3389\/fmicb.2023.1269392","volume":"14","author":"S Jalalifar","year":"2024","unstructured":"Jalalifar S, Razavi S, Mirzaei R, Irajian G, Pooshang Bagheri K (2024) A hope for ineffective antibiotics to return to treatment: investigating the anti-biofilm potential of melittin alone and in combination with penicillin and oxacillin against multidrug resistant-MRSA and-VRSA. Front Microbiol 14:1269392","journal-title":"Front Microbiol"},{"key":"890_CR20","doi-asserted-by":"publisher","first-page":"100606","DOI":"10.1016\/j.rechem.2022.100606","volume":"4","author":"E Kabir","year":"2022","unstructured":"Kabir E, Uzzaman M (2022) A review on biological and medicinal impact of heterocyclic compounds. Results Chem 4:100606","journal-title":"Results Chem"},{"key":"890_CR11","doi-asserted-by":"publisher","unstructured":"Kachhadiya DK, Georrge JJ (2025) Quorum sensing and its inhibition in Pseudomonas aeruginosa: molecular targets and mode of action. Curr Drug Targets 26(9):613\u2013631. https:\/\/doi.org\/10.2174\/0113894501373124250410105111","DOI":"10.2174\/0113894501373124250410105111"},{"issue":"1","key":"890_CR46","first-page":"35","volume":"13","author":"E Karimi","year":"2021","unstructured":"Karimi E, Ghalibafan F, Esfandani A, Arash NM, Mohammadi S, Khaledi A et al (2021) Antibiotic resistance pattern in Pseudomonas aeruginosa isolated from clinical samples other than burn samples in Iran. Avicenna J Med Biotechnol 13(1):35","journal-title":"Avicenna J Med Biotechnol"},{"issue":"21","key":"890_CR10","doi-asserted-by":"publisher","first-page":"7584","DOI":"10.3390\/molecules27217584","volume":"27","author":"L Kumar","year":"2022","unstructured":"Kumar L, Patel SKS, Kharga K, Kumar R, Kumar P, Pandohee J et al (2022) Molecular mechanisms and applications of N-acyl homoserine lactone-mediated quorum sensing in bacteria. Molecules 27(21):7584","journal-title":"Molecules"},{"issue":"10","key":"890_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2174\/0115734064354700241202174614","volume":"21","author":"S Lata","year":"2025","unstructured":"Lata S, Choudhary L, Bharwal A, Pandit A, Abbot V (2025) A comprehensive review: synthesis and pharmacological activities of 1, 3, 4-oxadiazole hybrid scaffolds. Med Chem 21(10):1051\u20131071","journal-title":"Med Chem"},{"key":"890_CR29","unstructured":"Lewis II, J.S. (2025) CLSI M100-Ed35 Performance standards for antimicrobial susceptibility testing standards. 35th edn, Clinical and Laboratory Standards Institute"},{"issue":"6","key":"890_CR18","doi-asserted-by":"publisher","first-page":"02209","DOI":"10.1128\/aac","volume":"61","author":"SH Lob","year":"2017","unstructured":"Lob SH, Hackel MA, Kazmierczak KM, Young K, Motyl MR, Karlowsky JA et al (2017) In vitro activity of imipenem-relebactam against gram-negative ESKAPE pathogens isolated by clinical laboratories in the United States in 2015 (results from the SMART global surveillance program). Antimicrob Agents Chemother 61(6):02209\u201302216. https:\/\/doi.org\/10.1128\/aac","journal-title":"Antimicrob Agents Chemother"},{"key":"890_CR39","unstructured":"Lorian V (2005) Antibiotics in laboratory medicine. Lippincott Williams & Wilkins"},{"issue":"3","key":"890_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas M, Giske C et al (2012) Multidrug-resistant, extensively drug\u2010resistant and pandrug\u2010resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"890_CR24","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.3390\/ijms27073018","volume":"27","author":"E Manni","year":"2026","unstructured":"Manni E, Hussein MF, Elkady S, Abdel-Rahman AA-H, Hawata MA, El-Sayed WA et al (2026) From synthesis to mechanism: Biological evaluation of ap-Toluidine-Based Thiazolidinone-Quinoline VEGFR-2 candidate supported by CADD. Int J Mol Sci 27(7):3018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"890_CR2","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3390\/ijerph19031338","volume":"19","author":"A Markiewicz-Gospodarek","year":"2022","unstructured":"Markiewicz-Gospodarek A, Kozio\u0142 M, Tobiasz M, Baj J, Radzikowska-B\u00fcchner E, Przekora A (2022) Burn wound healing: clinical complications, medical care, treatment, and dressing types: the current state of knowledge for clinical practice. Int J Environ Res Public Health 19(3):1338","journal-title":"Int J Environ Res Public Health"},{"key":"890_CR35","doi-asserted-by":"publisher","first-page":"869650","DOI":"10.3389\/fmicb.2022.869650","volume":"13","author":"R Mirzaei","year":"2022","unstructured":"Mirzaei R, Alikhani MY, Arciola CR, Sedighi I, Irajian G, Jamasbi E et al (2022) Highly synergistic effects of melittin with vancomycin and rifampin against vancomycin and rifampin resistant Staphylococcus epidermidis. Front Microbiol 13:869650","journal-title":"Front Microbiol"},{"key":"890_CR37","doi-asserted-by":"publisher","first-page":"112670","DOI":"10.1016\/j.biopha.2022.112670","volume":"147","author":"R Mirzaei","year":"2022","unstructured":"Mirzaei R, Alikhani MY, Arciola CR, Sedighi I, Yousefimashouf R, Bagheri KP (2022) Prevention, inhibition, and degradation effects of melittin alone and in combination with vancomycin and rifampin against strong biofilm producer strains of methicillin-resistant Staphylococcus epidermidis. Biomed Pharmacother 147:112670","journal-title":"Biomed Pharmacother"},{"key":"890_CR32","doi-asserted-by":"publisher","first-page":"1030401","DOI":"10.3389\/fmicb.2023.1030401","volume":"14","author":"R Mirzaei","year":"2023","unstructured":"Mirzaei R, Esmaeili Gouvarchin Ghaleh H, Ranjbar R (2023) Antibiofilm effect of melittin alone and in combination with conventional antibiotics toward strong biofilm of MDR-MRSA and-Pseudomonas aeruginosa. Front Microbiol 14:1030401","journal-title":"Front Microbiol"},{"issue":"1","key":"890_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21608\/jesj.2022.143610.1020","volume":"27","author":"MA Mohamed","year":"2022","unstructured":"Mohamed MA, Mohamed HA, Afifi MM (2022) Prevalence of MDR Pseudomonas aeruginosa in Intensive care units and burned patients. J Environ Stud 27(1):10\u201315","journal-title":"J Environ Stud"},{"issue":"1","key":"890_CR48","doi-asserted-by":"publisher","first-page":"25445","DOI":"10.1038\/s41598-025-11614-6","volume":"15","author":"SM Mondol","year":"2025","unstructured":"Mondol SM, Islam MR, Mia ME, Hassan MH, Farhad F, Akter K et al (2025) Molecular and genomic insights into multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa causing burn wound infections in Bangladesh. Sci Rep 15(1):25445","journal-title":"Sci Rep"},{"key":"890_CR12","doi-asserted-by":"publisher","unstructured":"Nadda AK, Sajna KV, Sharma S (eds) (2021) Molecular basis and genetic regulation of EPS. Microbial Exopolysaccharides as Novel and Significant Biomaterials. Springer, pp 45\u201383. https:\/\/doi.org\/10.1007\/978-3-030-75289-7","DOI":"10.1007\/978-3-030-75289-7"},{"issue":"1","key":"890_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13065-025-01626-8","volume":"19","author":"M Nazari","year":"2025","unstructured":"Nazari M, Hosseini SM (2025) Evaluation of antibacterial and antibiofilm efficacy of gentamicin-loaded solid lipid nanoparticles (GM-SLNs) against Acinetobacter baumannii infections. BMC Chem 19(1):269","journal-title":"BMC Chem"},{"issue":"1","key":"890_CR33","doi-asserted-by":"publisher","first-page":"1403019","DOI":"10.1155\/cjid\/1403019","volume":"2024","author":"M Nazari","year":"2024","unstructured":"Nazari M, Hemmati J, Asghari B (2024) Comprehensive analysis of virulence genes, antibiotic resistance, biofilm formation, and sequence types in clinical isolates of klebsiella pneumoniae. Can J Infect Dis Med Microbiol 2024(1):1403019","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"890_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12941-024-00760-w","volume":"23","author":"M Nazari","year":"2024","unstructured":"Nazari M, Taheri M, Nouri F, Bahmanzadeh M, Alikhani MY (2024) The antimicrobial and antibiofilm effects of gentamicin, imipenem, and fucoidan combinations against dual-species biofilms of Staphylococcus aureus and Acinetobacter baumannii isolated from diabetic foot ulcers. Ann Clin Microbiol Antimicrob 23(1):101","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"890_CR43","doi-asserted-by":"publisher","first-page":"fmed","DOI":"10.3389\/fmed.2025.1527662","volume":"12","author":"M Nazari","year":"2025","unstructured":"Nazari M, Alikhani MS, Hemmati J, Ahmadi A, Hashemi SH, Alikhani MY (2025) Exploring fluoroquinolone resistance mechanisms and the effects of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) in Acinetobacter baumannii. Front Med 12:fmed\u201312","journal-title":"Front Med"},{"issue":"2","key":"890_CR16","doi-asserted-by":"publisher","first-page":"e0342905","DOI":"10.1371\/journal.pone.0342905","volume":"21","author":"M Nazari","year":"2026","unstructured":"Nazari M, Taheri M, Nouri F, Bahmanzadeh M, Alikhani MY (2026) Synergistic effects of antibiotics and fucoidan on dual-species Staphylococcus aureus and Acinetobacter baumannii biofilm in diabetic rat wound models. PLoS ONE 21(2):e0342905","journal-title":"PLoS ONE"},{"issue":"1","key":"890_CR27","doi-asserted-by":"publisher","first-page":"39543","DOI":"10.1038\/s41598-025-23260-z","volume":"15","author":"A Rahimbakhsh","year":"2025","unstructured":"Rahimbakhsh A, Seyfahmadi M, Souldozi A, Hakimelahi R, Alikhani MY, Kafilzadeh F (2025) Effect of 1, 3, 4-oxadiazoles on expression of biofilm-associated bap gene in clinical isolates of multidrug-resistant Acinetobacter baumannii. Sci Rep 15(1):39543","journal-title":"Sci Rep"},{"issue":"6","key":"890_CR53","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1021\/acs.jafc.4c05674","volume":"73","author":"X Ren","year":"2025","unstructured":"Ren X, Liu Y, Wang F, Li C, Zhou X, Jin L (2025) 1, 3, 4-oxadiazole sulfonamide derivatives containing pyrazole structures: design, synthesis, biological activity studies, and mechanism study. J Agric Food Chem 73(6):3330\u20133340","journal-title":"J Agric Food Chem"},{"issue":"18","key":"890_CR3","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds D, Kollef M (2021) The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs 81(18):2117\u20132131","journal-title":"Drugs"},{"issue":"1","key":"890_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/sur.2020.129","volume":"22","author":"PM Robben","year":"2021","unstructured":"Robben PM, Ayalew MD, Chung KK, Ressner RA (2021) Multi-drug\u2013resistant organisms in burn infections. Surg Infect 22(1):103\u2013112","journal-title":"Surg Infect"},{"issue":"7","key":"890_CR45","doi-asserted-by":"publisher","first-page":"e71054","DOI":"10.1002\/hsr2.71054","volume":"8","author":"M Sadeghi","year":"2025","unstructured":"Sadeghi M, Mobayen M, Yaghubi Kalurazi T, Mehrdad Z, Gaskarei MK, Moghadam SK et al (2025) Epidemiological Trends and Evolving Antibiotic Resistance Profiles of Pseudomonas aeruginosa in Burn Patients: A 3-Year Cross\u2010Sectional Surveillance in Northern Iran. Health Sci Rep 8(7):e71054","journal-title":"Health Sci Rep"},{"issue":"7","key":"890_CR51","doi-asserted-by":"publisher","first-page":"11660","DOI":"10.3390\/molecules200711660","volume":"20","author":"L Shi","year":"2015","unstructured":"Shi L, Li P, Wang W, Gao M, Wu Z, Song X et al (2015) Antibacterial activity and mechanism of action of sulfone derivatives containing 1, 3, 4-oxadiazole moieties on rice bacterial leaf blight. Molecules 20(7):11660\u201311675","journal-title":"Molecules"},{"key":"890_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jgar.2020.12.002","volume":"24","author":"M Sivaranjani","year":"2021","unstructured":"Sivaranjani M, Liu F, White AP (2021) Synergistic activity of tetrasodium EDTA, ethanol and chlorhexidine hydrochloride against planktonic and biofilm cells of clinically relevant pathogens. J Global Antimicrob Resist 24:148\u2013157","journal-title":"J Global Antimicrob Resist"},{"key":"890_CR15","doi-asserted-by":"publisher","first-page":"1390765","DOI":"10.3389\/fmicb.2024.1390765","volume":"15","author":"S Taheri-Araghi","year":"2024","unstructured":"Taheri-Araghi S (2024) Synergistic action of antimicrobial peptides and antibiotics: current understanding and future directions. Front Microbiol 15:1390765","journal-title":"Front Microbiol"},{"issue":"5","key":"890_CR17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/antibiotics12050860","volume":"12","author":"M Thy","year":"2023","unstructured":"Thy M, Timsit J-F, de Montmollin E (2023) Aminoglycosides for the treatment of severe infection due to resistant gram-negative pathogens. Antibiotics 12(5):860","journal-title":"Antibiotics"},{"issue":"6","key":"890_CR21","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/cbdd.14100","volume":"100","author":"D Tiwari","year":"2022","unstructured":"Tiwari D, Narang R, Sudhakar K, Singh V, Lal S, Devgun M (2022) 1, 3, 4-oxadiazole derivatives as potential antimicrobial agents. Chem Biol Drug Des 100(6):1086\u20131121","journal-title":"Chem Biol Drug Des"},{"issue":"3","key":"890_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/biologics1030019","volume":"1","author":"A Vetrivel","year":"2021","unstructured":"Vetrivel A, Ramasamy M, Vetrivel P, Natchimuthu S, Arunachalam S, Kim G-S et al (2021) Pseudomonas aeruginosa biofilm formation and its control. Biologics 1(3):312\u2013336","journal-title":"Biologics"},{"key":"890_CR34","unstructured":"Wayne P (2011) Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing"},{"key":"890_CR40","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3389\/fmicb.2017.02125","volume":"8","author":"B Yang","year":"2017","unstructured":"Yang B, Lei Z, Zhao Y, Ahmed S, Wang C, Zhang S et al (2017) Combination susceptibility testing of common antimicrobials in vitro and the effects of sub-MIC of antimicrobials on Staphylococcus aureus biofilm formation. Front Microbiol 8:2125","journal-title":"Front Microbiol"},{"issue":"4","key":"890_CR1","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.3390\/ijms24043749","volume":"24","author":"W \u017bwiere\u0142\u0142o","year":"2023","unstructured":"\u017bwiere\u0142\u0142o W, Piorun K, Sk\u00f3rka-Majewicz M, Maruszewska A, Antoniewski J, Gutowska I (2023) Burns: classification, pathophysiology, and treatment: a review. Int J Mol Sci 24(4):3749","journal-title":"Int J Mol Sci"}],"container-title":["International Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-026-00890-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10123-026-00890-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-026-00890-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:04:06Z","timestamp":1788336246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10123-026-00890-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":58,"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s10123-026-00890-5","relation":{},"ISSN":["1618-1905"],"issn-type":[{"value":"1618-1905","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Review Board of the Hamadan University of Medical Sciences, Hamadan, Iran (Ethical approval code: IR.UMSHA.REC.1404.687) and the Ethics Review Board of the Baqiyatallah University of Medical Sciences, Tehran, Iran (Ethical approval code: IR.BMSU.BLC.1404.053) approved the present study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}